Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sandoz Canada

Division of Novartis AG
www.sandoz.ca

Latest From Sandoz Canada

Ranitidine Distribution Stops In Canada As Regulators Assess Contamination Threat

Health Canada asks ranitidine H2 blocker firms to halt sales until it gathers more information on NDMA contamination, which may form due to the drug’s instability. At least one marketer, Sandoz, also is recalling its ranitidine products in both Canada and US.

Europe Canada

Medical Device Deals Update, September 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced in late July-September 2014.

Medical Device Deals

FDA Recall Powers Should Be Limited, FDA Says

Agency argues it can’t recall generic versions of Precedex as part of Hospira’s patent suit.

BioPharmaceutical Regulation

Savoring Sabex: Sandoz' Play in Injectable Generics

Sandoz, the generics unit of Novartis, is buying Sabex, a Canadian maker of injectable generics for $565 million cash, marking its entree into an attractive sector of generics and also the Canadian generics market. The 6X sales multiple aimed to dissuade Sabex owners from shopping for another buyer. Novartis is the only big pharma company to succeed in generics. Its play is opportunistic, but a secondary effect is a free-market response to pressure on big pharma to make drugs more affordable.
BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
  • Therapeutic Areas
  • Dermatology
  • Neurology, Nervous System
  • Alias(es)
  • Sabex 2002 Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • Canada
  • Parent & Subsidiaries
  • Novartis AG
  • Senior Management
  • Michel Robidoux, Pres.
    Jacquelin Gagnon, VP, Sales & Mktg.
    Marc Beaudoin, VP, Strategy & Bus. Dev.
    Len Arsenault , VP, Scientific Affairs
    Martin Fournier, VP, Fin. & IT
  • Contact Info
  • Sandoz Canada
    Phone: (450) 641-4903
    145 Jules Leger
    Boucherville, J4B 7K8
    Canada
Advertisement
Advertisement
UsernamePublicRestriction

Register